|
Volumn 12, Issue 16, 2002, Pages 2149-2152
|
Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: Prevention of reactive intermediate formation and covalent binding
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE;
CATECHOL DERIVATIVE;
DRUG METABOLITE;
L 791 943;
L 971 943;
PHOSPHODIESTERASE IV INHIBITOR;
PROTEIN;
ROLIPRAM;
UNCLASSIFIED DRUG;
3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
CATECHOL;
PHOSPHODIESTERASE IV;
PYRIDINE DERIVATIVE;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
COVALENT BOND;
DRUG BLOOD LEVEL;
DRUG METABOLISM;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG SELECTIVITY;
DRUG STABILITY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
MICROSOME;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
LIVER MICROSOME;
METABOLISM;
PROTEIN BINDING;
3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE;
ANIMALS;
CATECHOLS;
MICROSOMES, LIVER;
MOLECULAR STRUCTURE;
PROTEIN BINDING;
PYRIDINES;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037136003
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00349-9 Document Type: Article |
Times cited : (60)
|
References (26)
|